ClinicalTrials.gg
RecruitingNCT07571668Updated Nov 18, 2026

Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral Palsy

An interventional study of Robotic Hand Therapy and Conventional physical Therapy in Cerebral Palsy, Hemiplegic, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 7 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 18, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
7 Years to 15 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 135 studies in Cerebral Palsy by Riphah International University — 37 open to participants now, 37 under way, none of them phase 3. Cerebral Palsy · Riphah International University.

Planned enrollment
6th of 125
70 · median 30
Started
2026
with 17 others
No phase
125 of 135
34 open now
Primary completion
2027-06
later than 34 of 36 live
Registered
120th of 135
by date

Among the 135 studies in Cerebral Palsy by Riphah International University, this one is the 6th largest by planned enrollment of the 125 interventional ones that give a count, is one of 18 that started in 2026, is one of 125 with no phase, reaches primary completion later than 34 of the 36 other live ones, and was the 120th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

37 of the 135 studies in Cerebral Palsy by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

31 more — sign in →

By country, each count listing its studies:

All 37 open studies →

Where they have run

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 7 Years to 15 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 135 studies in Cerebral Palsy by Riphah International University, or all of them as a file.
02

Study summary

This randomized controlled trial aims to evaluate the effects of robotic hand therapy using the Syrebo E12 soft-robotic glove compared with conventional physiotherapy on hand function and manual dexterity in children with hemiplegic cerebral palsy. Children aged 7-15 years, classified as GMFCS I-III and MACS I-III, will be recruited from multiple rehabilitation centers in Pakistan. Participants will be randomly allocated (1:1) to either robotic therapy or standard physiotherapy, receiving 45-minute sessions, three times per week for 8 weeks.

The primary outcome is functional hand performance measured by the Jebsen-Taylor Hand Function Test (JTHFT). Secondary outcomes include ABILHAND-Kids, Box and Block Test, Nine-Hole Peg Test, grip strength, and qualitative feedback. Assessments will occur at baseline, week 4, week 8, and at a 6-month follow-up. A mixed-effects repeated-measures ANCOVA will be used for analysis following the intention-to-treat principle.

03

Conditions studied

  • Cerebral Palsy, Hemiplegic

Keywords

  • cerebral palsy
  • hemiplegia
  • hand function
  • Robotic hand
  • Robotic Glove
04

Who can participate

Ages eligible
7 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with Hemiplegic type of Cerebral palsy
  • Age 7 to 15 years
  • Ability to understand and follow simple instructions
  • Gross Motor Function Classification System (GMFCS) levels I-III (ambulatory)
  • Manual Ability Classification system (MACS) I to III
  • Stable medical condition (no major changes in medication or therapy in the past 3 months).

Exclusion criteria

Exclusion Criteria:

  • Patients with severe cognitive dysfunction.
  • Fixed contractures or deformities of the upper limb that would prevent safe use of the robotic device.
  • Recent upper limb surgery, botulinum toxin injection, or casting within the past 6 months.
  • Uncontrolled epilepsy or other unstable medical conditions.
  • Visual or auditory impairments that would interfere with assessment or therapy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Robotic Hand Therapy

    Device: Robotic Hand Therapy

  • Active comparator
    Conventional Physical Therapy

    Other: Conventional physical Therapy

Interventions

  • DeviceRobotic Hand Therapy

    Participants in this group will receive robotic hand therapy using a glove-based robotic rehabilitation device that provides passive, active-assisted, and resistive training to facilitate repetitive, task-specific hand movements. Each 45-minute session will be delivered three times per week for six weeks under therapist supervision, focusing on improving grasp-release patterns, finger mobility, and functional hand use. Therapy intensity will be progressively adjusted based on performance and tolerance, and all sessions will be monitored for safety and adverse events.

  • OtherConventional physical Therapy

    Participants in this group will receive conventional physical therapy based on neurodevelopmental and task-oriented principles, including stretching, strengthening, sensory re-education, and functional hand-use training. Sessions will last 45 minutes, three times per week for six weeks, delivered by a licensed physical therapist following a standardized treatment checklist. The program targets improvements in hand strength, dexterity, range of motion, and fine motor skills, with safety and treatment fidelity monitored throughout.

06

What researchers measure

Primary outcomes

  1. Jebsen-Taylor Hand Function Test

    Jebsen-Taylor Hand Function Test (JTHFT) will objectively quantify functional capacity of hand.

    Time frame: 8 Weeks

Secondary outcomes

  1. ABILHAND-Kids

    ABILHAND-Kids for perceived manual ability in daily activities (Subjective assessment).

    Time frame: 8 Weeks

  2. Box and Block Test

    Box and Block Test \[BBT\] for unilateral gross manual dexterity

    Time frame: 8 Weeks

  3. Nine-Hole Peg Test (NHPT)

    Nine-Hole Peg Test (NHPT) fine finger dexterity (time to place and remove pegs)

    Time frame: 8 weeks

  4. o'connor test

    The O'Connor Finger Dexterity Test is a, standardized, timed, aptitude assessment designed to measure fine motor skills and rapid, precise manipulation of small objects. It is widely used in vocational testing, industrial hiring (assembly line work), and clinical rehab to evaluate finger dexterity by placing three pins into 100 holes.

    Time frame: 8 Weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for Jun 2027, 7 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 7 months is below that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

Start moved once since we started tracking on Sep 25, 2026: May 2026 → Nov 2026, on Nov 18, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2026
First posted
May 6, 2026
StartActual
Nov 10, 2026was May 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Sites
Riphah International University is now Recruiting
Nov 18, 2026
Start date
May 2026→Nov 10, 2026 (actual)
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    Riphah International University is now Recruiting
    Start date May 2026→Nov 10, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07571668
Responsible party
Sponsor
First posted
May 6, 2026
Start date
Nov 10, 2026
Primary completion
Jun 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Qamar Mehmood, Ph.D.
Contact
qamar.mehmood@riphah.edu.pk
+923335151063
Qamar Mehmood, Ph.D.
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion